Palbociclib
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-01 |
| Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China (NCT04526028) | Tianjin Medical University Cancer Institute and Hospital | 2019-09-13 |
Track Palbociclib automatically
Every clearance here is in the API, with alerts when new ones post.